Does BEVACIZUMAB Cause Polypoidal choroidal vasculopathy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Polypoidal choroidal vasculopathy have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.0% of all adverse event reports for BEVACIZUMAB.
5
Reports of Polypoidal choroidal vasculopathy with BEVACIZUMAB
0.0%
of all BEVACIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Polypoidal choroidal vasculopathy From BEVACIZUMAB?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Polypoidal choroidal vasculopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Polypoidal choroidal vasculopathy?
Which BEVACIZUMAB Alternatives Have Lower Polypoidal choroidal vasculopathy Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ